Vero E6 Cells
Vero E6 Cells - Related Videos
10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
0 Views •
Cited by 24 •
2013
Rescue of recombinant arenaviruses from cloned cDNAs, an approach referred to as reverse genetics, allows researchers to investigate the role of specific viral gene products, as well as the contribution of their different specific domains and residues, to many different aspects of the biology of arenavirus. Likewise, reverse genetics techniques in FDA-approved cell lines (Vero) for vaccine development provides novel possibilities for the generation of effective and safe vaccines to combat human...
07:23
Detection of Infectious Virus from Field-collected Mosquitoes by Vero Cell Culture Assay
0 Views •
Cited by 19 •
2011
We describe a method to process and screen field-collected mosquitoes for a diversity of viruses by Vero cell culture assay. By employing this technique, we have detected 9 different viruses from 4 taxonomic families in mosquitoes collected in Connecticut.
08:34
Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
0 Views •
Cited by 1 •
2016
The first step in the arenavirus life cycle is attachment of viral particles to host cells. We report a quantitative (q)RT-PCR-based assay for ultrasensitive detection and quantitation of arenavirus attachment events.
03:34
An In Vitro Assay to Study Arenavirus Attachment to the Host Cell
0 Views •
2026
Source: Klaus, J. P., et al Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment. J. Vis. Exp. (2016).This video demonstrates how to measure arenavirus attachment to monkey kidney cells. The assay uses low temperatures to block endocytosis and isolate the virus binding step. The approach enables precise quantification of surface-bound virus particles under conditions that restrict internalization.
10:25
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
0 Views •
2021
The protocol described here outlines a fast and effective method for measuring neutralizing antibodies against the SARS-CoV-2 spike protein by evaluating the ability of convalescent serum samples to inhibit infection by an enhanced green fluorescent protein-labeled vesicular stomatitis virus pseudotyped with spike glycoprotein.
FAQs
The inability of Vero E6 cells to produce type I interferon removes an important antiviral signaling response that would otherwise help limit viral replication. As a result, viruses may replicate more readily in this system, making infection easier to detect and compare. This feature is useful for studying viral growth, but it limits direct evaluation of intact interferon-mediated host defenses.
Reduced interferon-mediated antiviral signaling can increase cellular susceptibility to infection, allowing viral replication to produce visible changes in the cell population. These virus-induced alterations, called cytopathic effects, provide an observable outcome for infection experiments. Investigators can use them alongside infectivity measurements to assess whether a virus has successfully propagated or whether treatment changes the infection outcome.
Cytopathic effects indicate that infection has produced detectable changes in the cultured cells. Their presence can support an assessment of viral infectivity and propagation, while differences between experimental conditions may show that a compound or neutralizing antibody altered infection. Because these effects are measurable cellular outcomes, they help connect viral activity with visible consequences in the laboratory model.
A typical application begins by exposing Vero E6 cell cultures to a virus and then examining evidence of replication and infection-associated cellular change. Investigators may use the resulting cytopathic effects and other infectivity measurements to compare viral activity across samples. The same general model can also support virus propagation when reproducible laboratory growth is required.
Researchers can introduce an antiviral compound or neutralizing antibody into infection experiments and compare the resulting viral activity with an untreated or otherwise comparative condition. Changes in viral replication, infectivity, or cytopathic effects provide outcomes for judging the intervention. This makes the cells useful for screening antiviral activity and examining whether antibodies can reduce infection in culture.
Vero E6 cells provide a reproducible laboratory system for examining infection by emerging pathogens, including coronaviruses. Their susceptibility to viral replication supports virus propagation and infectivity studies, while measurable cellular responses help investigators assess infection-associated changes. In immunology and infection research, the model is especially informative for studying viral behavior and intervention effects, although its interferon deficiency does not represent a complete host response.